Skip to main content
Fig. 1 | BMC Endocrine Disorders

Fig. 1

From: Ultrasonography evaluation on the protective effect of combination therapy of beraprost sodium and aspirin on arteries occlusion and stiffness in patients with type 2 diabetes mellitus - a prospective, randomized study

Fig. 1

Study design. 64 patients were randomly assigned to the combined therapy group (32 patients), which received combination therapy with BPS (60 μg/day) and aspirin (100 mg/day), or to the control group (32 patients), which only received aspirin (100 mg/day). After randomization, the patients were followed up at year 0, 1, 2, 3, 4, and 5. BPS: beraprost sodium

Back to article page

BMC Endocrine Disorders

ISSN: 1472-6823

Contact us